Key statistics
On Tuesday, Lantheus Holdings Inc (0L8:MUN) closed at 54.88, 28.95% above the 52 week low of 42.56 set on Sep 23, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 54.88 |
|---|---|
| High | 54.88 |
| Low | 54.88 |
| Bid | 56.38 |
| Offer | 56.54 |
| Previous close | 54.96 |
| Average volume | 584.67 |
|---|---|
| Shares outstanding | 66.31m |
| Free float | 64.77m |
| P/E (TTM) | 27.39 |
| Market cap | 4.32bn USD |
| EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 07:01 GMT.
More ▼
Announcements
- Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
- Lantheus to Present Florbetaben F 18 Data at CTAD 2025
- Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
- Lantheus Announces Leadership Transition Plan
- Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
- Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
- Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
- Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
- Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
- Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
More ▼
